Style sheets must be enabled to view this page as it was intended.

Webcasts

Over the coming months we will be conducting a series of educational webcasts – please keep checking this page for regular updates.

05 August 2010
Microscale to Manufacture for Emerging Vaccine Technologies

Senior Purification Development Scientist, Jonathan Souquet discusses the growing demand for adenoviral vectors and how Eden Biodesign’s robust and scalable platform purification strategy overcomes the challenges of traditional approaches to adenoviral downstream processing, while increasing development and production rates, and significantly lowering manufacturing costs.

To view the archived presentation for on-demand viewing please click here.
A copy of the presentation slides can be obtained by clicking here.

17 December 2009
Viral Vectors: Overcoming Process Challenges to Meet the Clinical Demands

Dr David Simpson, Process Development Manager, discusses the recent resurgence of live viral products, how traditional research-based processes are having a difficult time keeping pace and ways Eden Biodesign developed a scalable suspension-based process in response to these increasing demands.

To view the archived presentation for on-demand viewing please click here.
A copy of the presentation slides can be obtained by clicking here.

10 November 2009
Monoclonal Antibody Production: Building the Platform

Andrew Clutterbuck, Purification Development Team Leader, discusses the challenges facing antibody manufacturers and ways Eden Biodesign can help overcome these obstacles.

To view the archived presentation for on-demand viewing please click here.
A copy of the presentation slides can be obtained by clicking here.

25 June 2009
Novel HPLC Method to Accelerate The Development of Adenoviral Vaccines

Dr. Phil Ball, Technical Director, discusses a novel approach to accelerate the development of adenoviral vaccines.

To view the archived presentation for on-demand viewing please click here.
A copy of the presentation slides can be obtained by clicking here.

20 November 2008
Accelerating Novel Vaccine Development from Bench to Clinic

Dr Roger Lias, President, Eden Biodesign, Inc. explores the challenges facing entrepreneurial organizations in identifying and managing appropriate development partners that understand the technical and regulatory issues that need to be addressed in order to accelerate products into and through clinical development.

To view the archived presentation for on-demand viewing please click here.
A copy of the presentation slides can be obtained by clicking here.

REGISTER FOR INFORMATION
RegisterTo find out more information about Eden Biodesign, our services and our track record please contact us to request a copy of our brochure. If you would like one of our team to get in touch, please submit your details via our registration form.